Liberty Biopharma Inc (CVE:LTY – Get Free Report) passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares changing hands.
Liberty Biopharma Price Performance
The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12. The stock’s 50-day moving average is C$2.00 and its 200 day moving average is C$2.00. The stock has a market capitalization of C$21.54 million and a PE ratio of -12.66.
About Liberty Biopharma
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Stories
- Five stocks we like better than Liberty Biopharma
- Breakout Stocks: What They Are and How to Identify Them
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- The 3 Best Blue-Chip Stocks to Buy Now
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Insider Buying Explained: What Investors Need to Know
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
